jurnal presentasi tht

30
Oncologic Benefit of Tonsillectomy in Stage I and II Tonsil Cancer Counselors: Dr. Agus surdawi, Sp. THT-KL Dr. Tris Sudyartono, Sp.THT-KL Dr. Afif Zjauhari, Sp.THT-KL JAMA OTOLARYNGOL HEAD NECK SURG/VOL 139 (NO. 4), APR 2013 Edited by Ermando Satria Utomo Lutfi Alfianto

Upload: febrian-naranggi-aradia-putra

Post on 07-Apr-2016

235 views

Category:

Documents


3 download

DESCRIPTION

aaa

TRANSCRIPT

Page 1: Jurnal Presentasi THT

Oncologic Benefit of Tonsillectomyin Stage I and II Tonsil Cancer

Counselors:Dr. Agus surdawi, Sp. THT-KLDr. Tris Sudyartono, Sp.THT-KLDr. Afif Zjauhari, Sp.THT-KL

JAMA OTOLARYNGOL HEAD NECK SURG/VOL 139 (NO. 4), APR 2013

Edited byErmando Satria Utomo

Lutfi Alfianto

Page 2: Jurnal Presentasi THT

Abstract

Page 3: Jurnal Presentasi THT

Study designRetospective

(tonsil cancer Cases from 1988-2006)

Treatment of low-stage tonsil cancer with radiotherapy is common, but the type of diagnostic procedure prior to radiotherapy varies. This study uses the Surveillance Epidemiology and End Results (SEER) registry to determine whether tonsillectomy or other surgical procedures prior to radiotherapy have an impact on outcome

Page 4: Jurnal Presentasi THT

Objective

To demonstrate whether tonsillectomy adds oncologic advantage over biopsy alone in stage I or II tonsil cancers prior to definitive radiotherapy

Page 5: Jurnal Presentasi THT

Subjects

Patient with stage I and II primary tonsil carcinoma who received definitive radiation treatment

Page 6: Jurnal Presentasi THT

Main Outcomes and Measure

• Hazard ratio 5 year DSS and 5 year OS• Analyse univariate and multivariate:– Sex– T1 vs T2–1988-2003 vs2004-2006–Preradiation tonsillectomy vs biopsy only

Page 7: Jurnal Presentasi THT

Results

• Radiation after tonsillectomy 5 year OS 83% And DSS 90%.• Radiation after biopsy 5 year OS 64% and DSS

76%.

Page 8: Jurnal Presentasi THT

Conclusion

• SEER data suggest that tonsil resection prior to radiation improved survival in low stage tonsil cancer (age and year of treatment controlled)

Page 9: Jurnal Presentasi THT

Introduction

Page 10: Jurnal Presentasi THT

• Squamous cell carcinoma tonsil most common cancer of the oropharynx past 30 years.

• National Comprehensive Cancer Network guidelines recommended RT or surgical resection with or without elective neck dissection for low stage tonsil cancer.

Page 11: Jurnal Presentasi THT

• Radical tonsillectomy in contrast not chose for diagnostic prosedur cause diagnostic procedure.

Page 12: Jurnal Presentasi THT

Metods

Page 13: Jurnal Presentasi THT

• 17 registries• Patient with T1 and T2

tumors and N0 neck disease

• 1988-2004 SEER

Page 14: Jurnal Presentasi THT

INCLUDE

• Patient registered from 1988-2004 •T1 and T2 and N0 • Neck disease negative• Neck dissections negative

EXCLUDE

• Patient registered after 2006

Page 15: Jurnal Presentasi THT

•T1 tumors up to 2 cm in greatest dimension•T2 tumors greater than 2 cm and up to 4 cm in greatest dimension

•T1 tumors up to 2 cm in greatest dimension•T2 tumors greater than 2 cm and up to 4 cm in greatest dimension

Page 16: Jurnal Presentasi THT

Surgery grouppatients who underwent diagnostic tonsillectomyor more extensive procedures

Control grouppatients who underwent incisional, needle, oraspiration biopsy of the primary site

Page 17: Jurnal Presentasi THT

Statistical AnalysisLog-rank test

UnivariateMultivariate

Page 18: Jurnal Presentasi THT

Results

Page 19: Jurnal Presentasi THT

• 524 patients with T1 and T2 tonsillar squamous cell or epitel cell tumor.

• Subgroup distribution T2 cancers >T1 (322 or 61%)

• Non surgical group > surgical group (2.5 times) for Hazard Ratio over 5 years.

• Patient register between 1988-2003 > 2004-2006 for Hazard ratio (HR: 2.55 DSS; HR:2.03 OS).

• 5 years DSS: surgical>non surgical (90% > 76%).

Page 20: Jurnal Presentasi THT
Page 21: Jurnal Presentasi THT
Page 22: Jurnal Presentasi THT
Page 23: Jurnal Presentasi THT
Page 24: Jurnal Presentasi THT

Discussion

• 2004-2006vs1988-2003younger age was also associated with survival benefit. Each of these parameters significantly affected OS and DSS, and significance was maintained in multivariate analysis.

Page 25: Jurnal Presentasi THT

Yildrim et al (1979-2004)• 120 total patient--> 20 had stage I or II disease.• 5 years OS stage I and II (100% and 77%).• Most patient (83%) had stage III or IV disease.

Our study (1988-2004)

• 524 total patient• 5 years OS stage I and II (83.2%).• our study focused exclusively on stage I and II cancer.

Page 26: Jurnal Presentasi THT

SEER database

• Lack information for margin status and local reccurrence

• Goal negative margins, our study positive margin

• Didn’t show patient age

Page 27: Jurnal Presentasi THT

Millier et al• SEER database 1998-2006 (updated)• increase of incidence tonsil cancer cause human papilloma virus (HPV) and how to effective treatment

Our study• SEER database 1988-2004 and 2004-2006 (longer frame time)

Page 28: Jurnal Presentasi THT

Increses of incidence tonsil cancer in the United States and abroad has also been reported by HPV prevalence in the oropharynx.

Page 29: Jurnal Presentasi THT

Nguyen et al

•SEER data 1974-2003•Excellent prognosis young age•Higher incidence HPV assosiated tumors in younger patients. Young patient may have better overall heatlh status.• this study used age as proxy for HPV status

Our study

•SEER data 1988-2004 and 2004-2006•Excellent prognosis young age•Young patient may have better overall heatlh status.• this study used age as proxy for overall health status

Page 30: Jurnal Presentasi THT

conclusionUse surgery or RT for early stage

tonsil cancer still remains controversial.

OS and DSS: RT after tonsillectomy better than is RT after biopsy alone.